Global Healthcare Biosensors IoT Market : North America will account for higher market share by Region driven by High demand for portable biosensors will lead the demand for healthcare biosensors IoT:Market Analysis and Forecast 2019 – 2026

Global Healthcare Biosensors IoT Market : North America will account for higher market share by Region driven by High demand for portable biosensors will lead the demand for healthcare biosensors IoT:Market Analysis and Forecast 2019 – 2026

Market Scenario

Global Healthcare Biosensors IoT Market size was valued over USD 17 billion in 2018 and is expected to witness growth of  XX % CAGR from 2019 to 2026. Global Healthcare Biosensors IoT Market is driven by growing awareness regarding diabetes self-management has enabled integration of advanced technology in the glucometers driving the Global Healthcare Biosensors IoT Market growth. For instance, newly developed glucometers have embedded microchips that allows accurate and quick detection of sugar levels at home. Rising preference for such technology variant diabetic biosensors have boosted the industry growth significantly. As per WHO, number of diabetic patients globally in 2016 were around 422 million that have escalated demand for glucose biosensors. Biosensors for measuring blood metabolites such as lactate, glucose, creatinine, and urea, using both optical and electrochemical modes of transduction, are being routinely used and commercially developed in the point of care testing, laboratories, and for self-testing in the case of glucose monitoring. Biosensors have applications in various segments in the healthcare industry. Global Healthcare Biosensors IoT Market, By Product Type Extended use of biosensors in various industries such as medical diagnostics, agricultural and food diagnostic industry has stimulated the demand for biosensors. Wide ranging applications of biosensors in diagnosis of various diseases such as diabetes, cholesterol, haemophilia will impact the industry demand positively. American population suffers from around 7000 rare diseases driving the demand for biosensors. Significant funding is been made in Europe by Max-Planck Institute in collaboration with the Federal Government of Germany and other German states. The European Molecular Biology Laboratory’s European Institute (EMBL-EBI) and BBSRC, with support by the UK Government, made a commitment of approximately USD 93 million for ELIXIR research infrastructure in 2012. In addition, the Chinese Government is also investing heavily on its computing infrastructure majorly via the China Grid initiated by Chinese Academy of Sciences and Ministry of Education and the China National Grid (CNGrid) supported by the Ministry of Science and Technology. Presence of such favourable initiatives is expected to have a positive impact on the biosensors market. The objective of the report is to present comprehensive Global Healthcare Biosensors IoT Market    including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Healthcare Biosensors IoT Market   North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Healthcare Biosensors IoT Market   North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Healthcare Biosensors IoT Market   North America for Asia Pacific make the report investor’s guide. Market Segmentation Global Healthcare Biosensors IoT Market, By Product Type • Wearable • Non-wearable Global Healthcare Biosensors IoT Market, By Technology • Electrochemical • Optical • Thermal • Piezoelectric • Others Global Healthcare Biosensors IoT Market, By Application • Blood glucose testing • Cholesterol testing • Blood gas analysis • Pregnancy testing • Drug Discovery • Infectious disease testing • Others Global Healthcare Biosensors IoT Market, By End Use • Point of care testing • Home healthcare diagnostics • Research laboratories • Others The above data will be provided for following regions/countries (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia Global Compounding Pharmacies Market

Table of Contents

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global healthcare biosensors IoT market overview 2.1.1. Product 2.1.2. Application 2.1.3. Therapeutic area Chapter 3 Global Healthcare Biosensors IoT Market, Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Rapid technological changes in U.S 3.2.1.2. Rising prevalence of diabetes globally 3.2.1.3. Extended applications in field of medical in U.S. 3.2.1.4. High demand for portable biosensors in Europe and Asia Pacific 3.2.2. Market restraints 3.2.2.1. Lack of skilled lab technicians and healthcare parishioners in developing economies 3.3. Market share analysis 3.3.1. By type 3.3.2. By technology 3.3.3. By medical application 3.3.4. By end-use 3.4. Reimbursements scenario 3.4.1. U.S. 3.4.2. Europe 3.5. Regulations landscape 3.5.1. U.S. 3.5.2. Europe 3.6. Competitive analysis 3.6.1. Key strategic initiatives 3.6.2. Regional presence 3.6.3. Product overview 3.7. Porter’s analysis 3.8. PESTEL analysis Chapter 4 Global Healthcare Biosensors IoT Market, By Product Type 4.1. Key segment trends 4.2. Wearable Devices 4.2.1. Market size, by region, 2019-2026 4.3. Non-wearable Devices 4.3.1. Market size, by region, 2019-2026 4.3.2. Key Trends in Global Healthcare Biosensors IoT Market Chapter 5 Global Healthcare Biosensors IoT Market, By Application 5.1. Key segment trends 5.2. Blood glucose testing 5.2.1. Market size, by region, 2019-2026 5.3. Cholesterol testing 5.3.1.1. Market size, by region, 2019-2026 5.4. Blood gas analysis 5.4.1.1. Market size, by region, 2019-2026 5.5. Pregnancy testing 5.5.1.1. Market size, by region, 2019-2026 5.6. Drug Discovery 5.6.1.1. Market size, by region, 2019-2026 5.7. Infectious disease testing 5.7.1.1. Market size, by region, 2019-2026 5.8. Others 5.8.1. Market size, by region, 2019-2026 Chapter 6 Global Healthcare Biosensors IoT Market, By Technology 6.1. Key segment trends 6.2. Electrochemical 6.2.1. Market size, by region, 2019-2026 6.3. Optical 6.3.1. Market size, by region, 2019-2026 6.4. Thermal 6.4.1. Market size, by region, 2019-2026 6.5. Piezoelectric 6.5.1. Market size, by region, 2019-2026 6.6. Others 6.6.1. Market size, by region, 2019-2026 Chapter 7 Global Healthcare Biosensors IoT Market, By End-Use 7.1. Point of care testing 7.1.1. Market size, by region, 2019-2026 7.2. Home healthcare diagnostics 7.2.1. Market size, by region, 2019-2026 7.3. Research laboratories 7.3.1. Market size, by region, 2019-2026 7.4. Others 7.4.1. Market size, by region, 2019-2026 Chapter 8 Global Healthcare Biosensors IoT Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market size, by country, 2019-2026 8.2.2. Market size, by type, 2019-2026 8.2.3. Market size, by application, 2019-2026 8.2.4. Market size, by technology, 2019-2026 8.2.5. Market size, by end users, 2019-2026 8.2.6. U.S. 8.2.6.1. Market size, by type, 2019-2026 8.2.6.2. Market size, by application, 2019-2026 8.2.6.3. Market size, by technology, 2019-2026 8.2.6.4. Market size, by end users, 2019-2026 8.2.7. Canada 8.2.7.1. Market size, by type, 2019-2026 8.2.7.2. Market size, by application, 2019-2026 8.2.7.3. Market size, by technology, 2019-2026 8.2.7.4. Market size, by end users, 2019-2026 8.3. Europe 8.3.1. Market size, by country, 2019-2026 8.3.2. Market size, by type, 2019-2026 8.3.3. Market size, by application, 2019-2026 8.3.4. Market size, by technology, 2019-2026 8.3.5. Market size, by end users, 2019-2026 8.3.6. Germany 8.3.6.1. Market size, by type, 2019-2026 8.3.6.2. Market size, by application, 2019-2026 8.3.6.3. Market size, by technology, 2019-2026 8.3.6.4. Market size, by end users, 2019-2026 8.3.7. UK 8.3.7.1. Market size, by type, 2019-2026 8.3.7.2. Market size, by application, 2019-2026 8.3.7.3. Market size, by technology, 2019-2026 8.3.7.4. Market size, by end users, 2019-2026 8.3.8. France 8.3.8.1. Market size, by type, 2019-2026 8.3.8.2. Market size, by application, 2019-2026 8.3.8.3. Market size, by technology, 2019-2026 8.3.8.4. Market size, by end users, 2019-2026 8.3.9. Spain 8.3.9.1. Market size, by type, 2019-2026 8.3.9.2. Market size, by application, 2019-2026 8.3.9.3. Market size, by technology, 2019-2026 8.3.9.4. Market size, by end users, 2019-2026 8.3.10. Italy 8.3.10.1. Market size, by type, 2019-2026 8.3.10.2. Market size, by application, 2019-2026 8.3.10.3. Market size, by technology, 2019-2026 8.3.10.4. Market size, by end users, 2019-2026 8.3.11. Russia 8.3.11.1. Market size, by type, 2019-2026 8.3.11.2. Market size, by application, 2019-2026 8.3.11.3. Market size, by technology, 2019-2026 8.3.11.4. Market size, by end users, 2019-2026 8.4. Asia Pacific 8.4.1. Market size, by country, 2019-2026 8.4.2. Market size, by type, 2019-2026 8.4.3. Market size, by application, 2019-2026 8.4.4. Market size, by technology, 2019-2026 8.4.5. Market size, by end users, 2019-2026 8.4.6. India 8.4.6.1. Market size, by type, 2019-2026 8.4.6.2. Market size, by application, 2019-2026 8.4.6.3. Market size, by technology, 2019-2026 8.4.6.4. Market size, by end users, 2019-2026 8.4.7. China 8.4.7.1. Market size, by type, 2019-2026 8.4.7.2. Market size, by application, 2019-2026 8.4.7.3. Market size, by technology, 2019-2026 8.4.7.4. Market size, by end users, 2019-2026 8.4.8. Japan 8.4.8.1. Market size, by type, 2019-2026 8.4.8.2. Market size, by application, 2019-2026 8.4.8.3. Market size, by technology, 2019-2026 8.4.8.4. Market size, by end users, 2019-2026 8.4.9. Australia 8.4.9.1. Market size, by type, 2019-2026 8.4.9.2. Market size, by application, 2019-2026 8.4.9.3. Market size, by technology, 2019-2026 8.4.9.4. Market size, by end users, 2019-2026 8.5. Latin America 8.5.1. Market size, by country, 2019-2026 8.5.2. Market size, by type, 2019-2026 8.5.3. Market size, by application, 2019-2026 8.5.4. Market size, by technology, 2019-2026 8.5.5. Market size, by end users, 2019-2026 8.5.6. Argentina 8.5.6.1. Market size, by type, 2019-2026 8.5.6.2. Market size, by application, 2019-2026 8.5.6.3. Market size, by technology, 2019-2026 8.5.6.4. Market size, by end users, 2019-2026 8.5.7. Brazil 8.5.7.1. Market size, by type, 2019-2026 8.5.7.2. Market size, by application, 2019-2026 8.5.7.3. Market size, by technology, 2019-2026 8.5.7.4. Market size, by end users, 2019-2026 8.5.8. Mexico 8.5.8.1. Market size, by type, 2019-2026 8.5.8.2. Market size, by application, 2019-2026 8.5.8.3. Market size, by technology, 2019-2026 8.5.8.4. Market size, by end users, 2019-2026 8.6. Middle East and Africa 8.6.1. Market size, by country, 2019-2026 8.6.1.1. Market size, by type, 2019-2026 8.6.1.2. Market size, by application, 2019-2026 8.6.1.3. Market size, by technology, 2019-2026 8.6.1.4. Market size, by end users, 2019-2026 8.6.2. South Africa 8.6.2.1. Market size, by type, 2019-2026 8.6.2.2. Market size, by application, 2019-2026 8.6.2.3. Market size, by technology, 2019-2026 8.6.2.4. Market size, by end users, 2019-2026 8.6.3. Saudi Arabia 8.6.3.1. Market size, by type, 2019-2026 8.6.3.2. Market size, by application, 2019-2026 8.6.3.3. Market size, by technology, 2019-2026 8.6.3.4. Market size, by end users, 2019-2026 Chapter 9 Consolidations 9.1. Mergers and Acquisitions 9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 9.3. Patent Analysis 9.4. Key players 9.4.1. Abbott Laboratories 9.4.1.1. Company overview 9.4.1.2. Key financials 9.4.1.3. Product landscape 9.4.1.4. Strategic initiatives 9.4.1.5. SWOT analysis 9.4.2. Bio-Rad International 9.4.2.1. Company overview 9.4.2.2. Key financials 9.4.2.3. Product landscape 9.4.2.4. Strategic initiatives 9.4.2.5. SWOT analysis 9.4.3. Biosensors International 9.4.3.1. Company overview 9.4.3.2. Key financials 9.4.3.3. Product landscape 9.4.3.4. Strategic initiatives 9.4.3.5. SWOT analysis 9.4.4. DuPont Biosensors Materials 9.4.4.1. Company overview 9.4.4.2. Key financials 9.4.4.3. Product landscape 9.4.4.4. Strategic initiatives 9.4.4.5. SWOT analysis 9.4.5. Ercon Inc 9.4.5.1. Company overview 9.4.5.2. Key financials 9.4.5.3. Product landscape 9.4.5.4. Strategic initiatives 9.4.5.5. SWOT analysis 9.4.6. Gwent Group 9.4.6.1. Company overview 9.4.6.2. Key financials 9.4.6.3. Product landscape 9.4.6.4. Strategic initiatives 9.4.6.5. SWOT analysis 9.4.7. Innovative Biosensors 9.4.7.1. Company overview 9.4.7.2. Key financials 9.4.7.3. Product landscape 9.4.7.4. Strategic initiatives 9.4.7.5. SWOT analysis 9.4.8. Johnson & Johnson 9.4.8.1. Company overview 9.4.8.2. Key financials 9.4.8.3. Product landscape 9.4.8.4. Strategic initiatives 9.4.8.5. SWOT analysis 9.4.9. Molecular Devices Corp 9.4.9.1. Company overview 9.4.9.2. Key financials 9.4.9.3. Product landscape 9.4.9.4. Strategic initiatives 9.4.9.5. SWOT analysis 9.4.10. Pinnacle Technology 9.4.10.1. Company overview 9.4.10.2. Key financials 9.4.10.3. Product landscape 9.4.10.4. Strategic initiatives 9.4.10.5. SWOT analysis 9.4.11. QTL Biosystems 9.4.11.1. Company overview 9.4.11.2. Key financials 9.4.11.3. Product landscape 9.4.11.4. Strategic initiatives 9.4.11.5. SWOT analysis 9.4.12. Roche Diagnostics 9.4.12.1. Company overview 9.4.12.2. Key financials 9.4.12.3. Product landscape 9.4.12.4. Strategic initiatives 9.4.12.5. SWOT analysis 9.4.13. SDIX, LLC 9.4.13.1. Company overview 9.4.13.2. Key financials 9.4.13.3. Product landscape 9.4.13.4. Strategic initiatives 9.4.13.5. SWOT analysis 9.4.14. Siemens Healthcare, LLC 9.4.14.1. Company overview 9.4.14.2. Key financials 9.4.14.3. Product landscape 9.4.14.4. Strategic initiatives 9.4.14.5. SWOT analysis 9.4.15. TE connectivity Corporation 9.4.15.1. Company overview 9.4.15.2. Key financials 9.4.15.3. Product landscape 9.4.15.4. Strategic initiatives 9.4.15.5. SWOT analysis 9.4.16. Thermo fisher 9.4.16.1. Company overview 9.4.16.2. Key financials 9.4.16.3. Product landscape 9.4.16.4. Strategic initiatives 9.4.16.5. SWOT analysis 9.4.17. Biosensors International 9.4.17.1. Company overview 9.4.17.2. Key financials 9.4.17.3. Product landscape 9.4.17.4. Strategic initiatives 9.4.17.5. SWOT analysis 9.4.18. Axela Biosensors 9.4.18.1. Company overview 9.4.18.2. Key financials 9.4.18.3. Product landscape 9.4.18.4. Strategic initiatives 9.4.18.5. SWOT analysis 9.4.19. Advanced Biosensor 9.4.19.1. Company overview 9.4.19.2. Key financials 9.4.19.3. Product landscape 9.4.19.4. Strategic initiatives 9.4.19.5. SWOT analysis 9.4.20. Atonomics A/S 9.4.20.1. Company overview 9.4.20.2. Key financials 9.4.20.3. Product landscape 9.4.20.4. Strategic initiatives 9.4.20.5. SWOT analysis 9.4.21. Blu-Si 9.4.21.1. Company overview 9.4.21.2. Key financials 9.4.21.3. Product landscape 9.4.21.4. Strategic initiatives 9.4.21.5. SWOT analysis 9.4.22. Piribo 9.4.22.1. Company overview 9.4.22.2. Key financials 9.4.22.3. Product landscape 9.4.22.4. Strategic initiatives 9.4.22.5. SWOT analysis 9.4.23. Biacore 9.4.23.1. Company overview 9.4.23.2. Key financials 9.4.23.3. Product landscape 9.4.23.4. Strategic initiatives 9.4.23.5. SWOT analysis 9.4.24. Sysmex Corporation 9.4.24.1. Company overview 9.4.24.2. Key financials 9.4.24.3. Product landscape 9.4.24.4. Strategic initiatives 9.4.24.5. SWOT analysis 9.4.25. Pharmaco-Kinesis Corporation 9.4.25.1. Company overview 9.4.25.2. Key financials 9.4.25.3. Product landscape 9.4.25.4. Strategic initiatives 9.4.25.5. SWOT analysis 9.4.26. Profosa 9.4.26.1. Company overview 9.4.26.2. Key financials 9.4.26.3. Product landscape 9.4.26.4. Strategic initiatives 9.4.26.5. SWOT analysis 9.4.27. Labiotech 9.4.27.1. Company overview 9.4.27.2. Key financials 9.4.27.3. Product landscape 9.4.27.4. Strategic initiatives 9.4.27.5. SWOT analysis 9.4.28. Philips 9.4.28.1. Company overview 9.4.28.2. Key financials 9.4.28.3. Product landscape 9.4.28.4. Strategic initiatives 9.4.28.5. SWOT analysis 9.4.29. biovation 9.4.29.1. Company overview 9.4.29.2. Key financials 9.4.29.3. Product landscape 9.4.29.4. Strategic initiatives 9.4.29.5. SWOT analysis 9.4.30. OSP labs 9.4.30.1. Company overview 9.4.30.2. Key financials 9.4.30.3. Product landscape 9.4.30.4. Strategic initiatives 9.4.30.5. SWOT analysis

About This Report

Report ID10631
Published Dateoct 2019
Contact Us
Call Now